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Poster Abstract 
A bioreactor scale-down model is an essential element in process development and 
commercialization. In this poster presentation, key strategies in bioreactor scale-down 
model development and characterization will be discussed.  A 4-Liter bioreactor scale-
down model was developed to emulate a 15,000-Liter commercial scale bioreactor.  Mass 
transfer characterization studies were conducted for the 15,000-Liter bioreactor, from 
which the results were summarized and utilized to guide scale-down model development / 
characterization.  Case studies are shown where scale-down model representativeness is 
enhanced by implementing PAT. Specifically, automated dissolved carbon dioxide (pCO2) 
control was implemented during scale-down model development in order to establish a  
more representative scale-down model.  Establishing pCO2 control with a feedback control 
loop significantly enhanced the ability of the scale-down bioreactor model to perform 
comparably with the 15,000 L commercial bioreactor.  
